73 related articles for article (PubMed ID: 9037954)
21. Update on cervical cancer screening. Current diagnostic and evidence-based management protocols.
Ball C; Madden JE
Postgrad Med; 2003 Feb; 113(2):59-64, 70. PubMed ID: 12611115
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer in Latin America.
Eluf-Neto J; Nascimento CM
Semin Oncol; 2001 Apr; 28(2):188-97. PubMed ID: 11301382
[TBL] [Abstract][Full Text] [Related]
23. [The value of screening using cervicography in dysplasia and neoplasms of the uterine cervix].
Coibion M; Guenier C; Miloiu A; Andry M; Bonnal JL; Nogaret JM
Rev Med Brux; 1990; 11(1-2):16-20. PubMed ID: 2406832
[TBL] [Abstract][Full Text] [Related]
24. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
26. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
Franco EL
J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
[TBL] [Abstract][Full Text] [Related]
27. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].
Kahng J; Lee HJ
Korean J Lab Med; 2008 Feb; 28(1):70-8. PubMed ID: 18309258
[TBL] [Abstract][Full Text] [Related]
28. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
[TBL] [Abstract][Full Text] [Related]
29. Screening for cervical cancer. Current terminology, classification, and technique.
Fowler J
Postgrad Med; 1993 Feb; 93(2):57-64, 70. PubMed ID: 8381956
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
[TBL] [Abstract][Full Text] [Related]
31. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer.
Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL
Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534
[TBL] [Abstract][Full Text] [Related]
32. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
34. An epidemiologic study of Papanicolaou smear data at Ain-Shams University hospitals.
Fahim HI; Faris R; Arab SE; Sammour MB
J Egypt Public Health Assoc; 1991; 66(1-2):97-111. PubMed ID: 1800628
[TBL] [Abstract][Full Text] [Related]
35. Increase Pap smear uptake.
Zardawi I
Med J Aust; 1998 Mar; 168(5):252. PubMed ID: 9539906
[No Abstract] [Full Text] [Related]
36. Comparative study between Pap smear cytology and FTIR spectroscopy: a new tool for screening for cervical cancer.
El-Tawil SG; Adnan R; Muhamed ZN; Othman NH
Pathology; 2008 Oct; 40(6):600-3. PubMed ID: 18752127
[TBL] [Abstract][Full Text] [Related]
37. Is it now time to evaluate the true accuracy of cervical cytology screening? A review of the literature.
Martin-Hirsch PL; Koliopoulos G; Paraskevaidis E
Eur J Gynaecol Oncol; 2002; 23(4):363-5. PubMed ID: 12214747
[TBL] [Abstract][Full Text] [Related]
38. The Polarprobe--emerging technology for cervical cancer screening.
Quek SC; Mould T; Canfell K; Singer A; Skladnev V; Coppleson M
Ann Acad Med Singap; 1998 Sep; 27(5):717-21. PubMed ID: 9919348
[TBL] [Abstract][Full Text] [Related]
39. [Risk-adapted multimodal laboratory cervical screening---Pap test of the future?].
Bollmann R; Varnai AD; Bankfalvi A; Bollmann M
Pathologe; 2007 Sep; 28(5):334-8. PubMed ID: 17661045
[TBL] [Abstract][Full Text] [Related]
40. Screening for cervical cancer: different problems in the developing and the developed world.
Symonds RP
Eur J Cancer Care (Engl); 1997 Dec; 6(4):275-9. PubMed ID: 9460347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
